[PHARMA] QoQ Quarter Result on 30-Jun-2021 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- -40.77%
YoY- 37.33%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 962,174 711,718 2,132,675 1,177,123 793,499 634,583 624,804 33.38%
PBT 37,439 125,088 98,219 22,244 31,524 -13,506 4,093 337.96%
Tax -8,583 -39,923 -47,895 -8,356 -8,696 6,459 -2,799 111.21%
NP 28,856 85,165 50,324 13,888 22,828 -7,047 1,294 693.76%
-
NP to SH 27,734 85,475 49,835 13,704 23,136 -6,331 1,442 619.14%
-
Tax Rate 22.93% 31.92% 48.76% 37.57% 27.59% - 68.39% -
Total Cost 933,318 626,553 2,082,351 1,163,235 770,671 641,630 623,510 30.88%
-
Net Worth 413,947 450,411 391,428 357,275 355,919 337,298 345,040 12.91%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div 10,479 65,466 26,182 19,630 10,468 2,614 3,920 92.73%
Div Payout % 37.79% 76.59% 52.54% 143.25% 45.25% 0.00% 271.91% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 413,947 450,411 391,428 357,275 355,919 337,298 345,040 12.91%
NOSH 1,309,126 1,309,336 1,309,126 261,991 261,705 261,705 261,705 192.77%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 3.00% 11.97% 2.36% 1.18% 2.88% -1.11% 0.21% -
ROE 6.70% 18.98% 12.73% 3.84% 6.50% -1.88% 0.42% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 73.45 54.36 162.91 89.95 303.20 242.70 239.03 -54.49%
EPS 2.12 6.53 3.81 1.05 8.84 -2.42 0.55 146.04%
DPS 0.80 5.00 2.00 1.50 4.00 1.00 1.50 -34.25%
NAPS 0.316 0.344 0.299 0.273 1.36 1.29 1.32 -61.47%
Adjusted Per Share Value based on latest NOSH - 261,991
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 66.76 49.38 147.97 81.67 55.06 44.03 43.35 33.39%
EPS 1.92 5.93 3.46 0.95 1.61 -0.44 0.10 618.31%
DPS 0.73 4.54 1.82 1.36 0.73 0.18 0.27 94.19%
NAPS 0.2872 0.3125 0.2716 0.2479 0.247 0.234 0.2394 12.91%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 0.755 0.74 0.835 5.29 3.26 5.00 4.32 -
P/RPS 1.03 1.36 0.51 5.88 1.08 2.06 1.81 -31.35%
P/EPS 35.66 11.34 21.93 505.18 36.88 -206.50 783.09 -87.27%
EY 2.80 8.82 4.56 0.20 2.71 -0.48 0.13 675.57%
DY 1.06 6.76 2.40 0.28 1.23 0.20 0.35 109.46%
P/NAPS 2.39 2.15 2.79 19.38 2.40 3.88 3.27 -18.87%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 -
Price 0.72 0.76 0.845 0.925 4.03 3.49 5.72 -
P/RPS 0.98 1.40 0.52 1.03 1.33 1.44 2.39 -44.83%
P/EPS 34.01 11.64 22.20 88.34 45.59 -144.14 1,036.87 -89.77%
EY 2.94 8.59 4.51 1.13 2.19 -0.69 0.10 854.53%
DY 1.11 6.58 2.37 1.62 0.99 0.29 0.26 163.40%
P/NAPS 2.28 2.21 2.83 3.39 2.96 2.71 4.33 -34.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment